Taking the complexity out of global track and trace requirements
With time running out, Meditraq launches to simplify serialisation data challenge.
A new serialisation implementation partner has formed to assist the increasing number of companies needing to meet the data requirements of looming global regulation changes.
In general, the pharmaceutical industry has been slow to adopt serialisation. The Tjoa Group started exploring the potential of track & trace in 2007, being one of the first in the world to realise full serialisation and aggregation from blister pocket to pallet in 2008. It is not until recently, however, that the industry has started to introduce regulations such as the EU Falsified Medicines Directive (FMD) and the US Drug Supply Chain Security Act (DSCSA).
"Serialisation is a huge task and those companies who have delayed their preparations are now facing an uphill battle to compliance. For many companies at this late stage, implementing their own solution is simply not achievable due to resource constraints, and for others, cost is a huge barrier. Timing is crucial and it is running out, which is why many companies are turning to partners to help ensure a fully compliant solution is in place ahead of the deadlines," said Dexter Tjoa, Co-founder of Meditraq.
With the pharmaceutical industry struggling to meet serialisation requirements in over 55 countries, Meditraq supports its customers with the deployment of serialisation software solutions.
Part of the Tjoa Group, together with contract packaging organisation (CPO) Tjoapack, the newly formed business provides an outsourced solution to the serialisation data challenge, supporting companies with the implementation and management of technology for the safe and secure exchange of serialisation data.
Commenting on the announcement of the company launch, Dexter Tjoa said: “One of the greatest challenges of complying with global track and trace requirements is the complexity of managing and sharing huge volumes of data throughout the pharmaceutical supply chain.
“Given our team has been involved in the serialisation world for over 25 years through Tjoapack’s contract packaging services, we have recognised a need in the market for greater support to overcome the serialisation data challenge, and this has driven the decision to establish Meditraq. Quite simply, we take care of our customers’ serialisation data requirements, meaning hassle-free compliance with global regulations.”
Meditraq’s services include onboarding all supply chain partners and internal manufacturing sites with the necessary software to ensure serialisation data management and exchange. In addition, it encompasses ongoing support and compliance services such as the management of master data, sending data between relevant parties, monitoring transactions, and solving exceptions involving serialised data.
"Currently, Meditraq’s primary focus is helping our customers to implement level 4 and 5 systems that can cater for serialisation data management and exchange, while also onboarding supply chain partners. Once the compliance deadlines have passed, we will continue to provide ongoing support for our customers in terms of managing and transferring the vast amounts of serialisation data that will be generated. We will also be helping them to adapt as the regulatory landscape evolves, ensuring they remain compliant," said Dexter Tjoa.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance